Late results of multiple fractions per day (MFD) with misonidazole in advanced cancer of the head and neck. A pilot study of the EORTC radiotherapy group
- 28 February 1985
- journal article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 3 (2) , 139-144
- https://doi.org/10.1016/s0167-8140(85)80018-9
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Implications of the quadratic cell survival curve and human skin radiation “tolerance doses” on fractionation and superfractionation dose selectionInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Clinical trials of radiation sensitizers in Head and neck cancerInternational Journal of Radiation Oncology*Biology*Physics, 1981
- Preliminary results in advanced head and neck cancer with radiotherapy by multiple fractions a dayClinical Radiology, 1980
- Misonidazole—A drug for trial in radiotherapy and oncologyInternational Journal of Radiation Oncology*Biology*Physics, 1979
- Carcinoma of the supraglottic larynxAmerican Journal of Roentgenology, 1979
- Preliminary results using twice-a-day fractionation in the radiotherapeutic management of advanced cancers of the head and neckAmerican Journal of Roentgenology, 1977
- Failure analysis of radical radiation therapy of supraglottic laryngeal carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1977
- Experience with twice-a-day fractionation in clinical radiotherapyAmerican Journal of Roentgenology, 1976
- Radiotherapy by several sessions a dayThe British Journal of Radiology, 1975
- A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorshipBiometrika, 1970